2022 Clinical Scientist Development Award: Doris Duke Charitable Foundation Announcement

The Doris Duke Charitable Foundation
2022 Clinical Scientist Development Award competition is now open

Pre-proposal applications are being sought from Assistant Professor physician scientists conducting clinical research in any disease area. Click here to find out more about the eligibility criteria and how to prepare an application.

The Doris Duke Charitable Foundation recognizes that a diverse workforce that represents the demographics of the population of the United States is better poised to address health issues affecting all communities. DDCF strongly encourages individuals from groups underrepresented in biomedical research to apply because DDCF is committed to the retention and advancement of early-career physician scientists who are conducting seminal clinical research and who belong to populations whose exclusion from research based on their race, ethnicity, gender, disability, sexual orientation, or socioeconomic background has resulted in underrepresentation in the workforce.

Application Deadlines
Eligibility exemption requests due: October 15, 2021, 5pm ET
Pre-proposal applications due: November 12, 2021, 3 pm ET
Invitation to submit full proposal: By 5 pm ET on January 14, 2022
Full proposals due: March 11, 2022, 3 pm ET
Award start date: July 1, 2022

The Clinical Scientist Development Award does not require institutional nomination. This competition employs a two-stage process. Pre-proposal applications will be reviewed and approximately 50 applicants will be invited to submit a full proposal.

In keeping with the wishes expressed in Doris Duke’s will, experiments that use animals or tissues derived from animals, including cell lines, will not be supported by this program.

Brain Barrier Virtual Meeting

The seventh Cold Spring Harbor conference on Brain Barriers is going virtual and will begin with a late morning session on Wednesday, April 7 and conclude late afternoon on Friday, April 9, 2021.

The purpose of this Cold Spring Harbor meeting is to explore and encourage new conceptual approaches and to apply novel methods to the neuroprotective physiologies of BBB structures. Our goal is pair genetic model organism biological methods with recent insights in vertebrate BBB physiology and development. We hope to create cross fertilization between fields that rarely see each other and get people thinking about how model systems can help parse the regulatory networks necessary for parsimonious BBB function.

The conference is intended to foster cross-disciplinary exchange of ideas and expertise between developmental and evolutionary biologists, vascular and BBB physiologists and disease oriented industry scientists interested in modifying or circumventing specific pathways of neuroprotection. While a number of speakers have been invited, please note that the majority of oral presentations will be drawn from openly submitted abstracts. The abstract deadline is January 29, 2021.

Organizers
Dritan Agalliu, Columbia University
Maria Lehtinen, Boston Children’s Hospital
Benoit Vanhollebeke, Universite Libre de Bruxelles, Belgium

Topics
Emerging Concepts and Hot Topics in CNS Barriers
Imaging Approaches to Study CNS Barriers
Development, Plasticity and Specialization of CNS Barriers
Systems, Computational and Cell Biology of the CNS Barriers
Neuroimmune Interactions Across CNS Barriers
CNS Barriers in Aging, Senescence and Neurodegeneration

Panel Discussion: “The brilliance barrier Stereotypes about brilliance are an obstacle to diversity in science and beyond”.

Workshop: “How to frame and write constructive, fair peer-review”

For more information, visit the Brain Barriers meeting website.

Hydrocephalus Society Global Webinar Series on iNPH

The Hydrocephalus Society Board of Directors has developed a virtual scientific and educational programme, consisting of six free of charge webinars, dealing with idiopathic Normal Pressure Hydrocephalus (iNPH) to provide hydrocephalus-related training opportunities.

Part 1 of the Global Webinar Series begins on November 20, 2020!

For our first topic “Clinical work-up” we are pleased to announce 3 distinguished speakers:

  • When should we suspect iNPH? (Intro, epidemiology) by Mark Hamilton
  • Which are the typical clinical symptoms? The clinical syndrome of iNPH: gait & balance, cognition, urinary by Giorgio Palandri
  • The typical radiological picture. CT, MR by Karin Kockum

We hope to see you all there and stay tuned for all our upcoming and exciting webinars!

Download the programme outline for the Global Webinar Series here!

Register for Part 1 to here!

Newborn Screening Summit: Sept. 8-10

NBSTRN is excited to host the Newborn Screening (NBS) Virtual Summit to celebrate newborn screening awareness month in September.

Attend the online summit on Sept 8-10, 2020 from 9 am to 12 pm (PST).

The event is free, but you must register at www.nbstrn.org. Once you registered, you will receive a separate email with the Zoom information to attend the virtual summit.

Here is the fantastic line-up of speakers on the latest newborn screening research.

Speaker Line-up (in PST time zone):

Sept 8, 2020

  • 9 am – Dr. Curt Scharfe, Machine Learning in NBS
  • 10 am – Dr. Tracy Trotter, Hearing Differences
  • 11 am – Terri Klein, Advocacy and NBS

Sept 9, 2020

  • 9 am – Dr. Jennifer Kwon, Spinal Muscular Atrophy
  • 10 am – Dr. Wendy Chung, Congenital Heart Disease
  • 11 am – Dr. Ronald Wapner and Jessica Giordano, Prenatal Genetics

Sept 10, 2020

  • 9 am – John Boyle, Alissa Huston, Lynn Albizo, Advocacy, and NBS
  • 10 am – Kim Piper, Community Engagement
  • 11 am – Dr. Michele Puryear, Sickle Cell Diseases

Each speaker will speak for 30-minutes, following a 15-minutes live-chat messaging session with attendees. The summit will take place online virtually using the Zoom meeting platform.

Be informed. Be transformed with new research.

To learn more about newborn screening research, visit www.nbstrn.org

This project has been funded in whole or in part with Federal funds from the NICHD, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201800005C.

 

A Virtual Experimental Biology in 2021

Given the ongoing COVID-19 pandemic, Experimental Biology has been forced to cancel our in-person meeting in Indianapolis, Indiana, May 1-4, 2021. However, we will offer Experimental Biology in a virtual format, which means that you and your colleagues will have many new and exciting opportunities for scientific discovery without travel.

Our new virtual meeting will bring you the latest research in anatomy, biochemistry, molecular biology, investigative pathology, pharmacology, and physiology. The 2021 dates will be announced soon.

What will our new virtual conference look like? Well, that’s up to you!

Please take five minutes to complete this brief survey by August 14, 2020. Your input will make Experimental Biology 2021 a creative and stimulating meeting that delivers the outstanding scientific content you expect.

As a thank-you for sharing your ideas, you can enter into a drawing for a $100 Amazon gift card.